US 10596259
Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof
granted A61KA61K38/05A61K41/0038
Quick answer
US patent 10596259 (Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof) held by The Regents of the University of California expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/05, A61K41/0038, A61K47/55, A61K47/64